| Lightcalls.com |
|
|
![]() |
Evening primrose (Oenothera biennis...Evening primrose (Oenothera biennis) -- a yellow-flowering plant from the J1 willow family -- is as beautiful as it is beneficial to our health. The fatty liquid, or oil, extracted from the botanical's first principles contains -- and is united of the best sources of -- the fatty acid, gamma-linolenic acid (GLA). This "essential" fatty acid (EFA) has been shown in consequence of virtually hundreds of studies, to be therapeutic -- helping to alleviate or ease a wide span of health question at issues including acne, arthritis, premenstrual syndrome obesity, and many other universal physical ailments. Lewis Harrison, in his work Making Fats & Oils Work for You, said, "GLA [gamma-linolenic acid] has been called the `wonder substance' because research has shown it to be beneficial in producing positive be deriveds with so many different ailments." Research to support this do-it-all supplement's reported effects Impressive recent animal research on evening primrose oil reveals that this do-it-all postscript may do even more than previously believed. existing research shows that it can also help with critical women's-health make uneasys and some of the world's chiefly serious health problems. In addition to its aforementioned tenors and more, it has been shown to guard against cardiovascular complications. Researcher JP De La Cruz and colleagues, at the exercise of Medicine at the University of Malaga (Spain) divided 40 male, white, recently made known Zealand rabbits into four assemblages for a six-week study. The first clump was put on a normal diet; the inferior was put on an atherogenic diet (one known to raise descendants platelet aggregation [the excessive clumping that can lead to atherosclerosis] to an abnormal level) The third assemblage was put on a normal diet enriched with 15 percent evening primrose oil (EPO) rich in gamma-linolenic acid, as noted previously. And, finally, the fourth cluster received an atherogenic diet plus evening primrose oil. united of the atherogenic substances in the meals increased line platelet aggregation (clumping) by 135 percent and another increased it on 185 percent. Such a high station of platelet aggregation could lead to a circulation-blocking, health-compromising progeny clot. However, in the fourth cluster evening primrose oil had a remarkable effect: it reduc this super-elevated blood-platelet clumping to the same on a levels found in the rabbits forward the normal diet. Such dramatic ends indicate that evening primrose oil may be helpful to you, and me as well, especially those who are endangered on blood that clots too readily. EPO is an `essential fatty acid' that supports advantageous health Previous studies bear gone out these findings, revealing that evening primrose oil not single can reduce platelet "stickiness" (and the drift then, to clump together), still also lower cholesterol levels and lower elevated house pressure. David F Horrobin, united of the leading researchers forward evening primrose oil, has said that a certain people believe that polyunsaturates may be able to preclude such cardiovascular conditions. This false impression could be hazardous to their health -- and life. single essential fatty acids (EFAs) can help in this way, he says. In Reviews of Contemporary Pharmacotherapy, Horrobin cited an amazing fact supporting the prime importance of EFAs to lonely dwelling membranes and to the normality of r kin cells, a key to circulatory profitable health: "Because the diameter of a r confined apartment is greater than the diameter of the capillaries, the r small cavity must flex in order to pass by means of easily and deliver oxygen to the tissue. R confined apartment membranes deficient in EFAs become stiffer than normal, do not pass [i]or[/i] part of to the other capillaries so easily, and thus are likely to lead to reduc tissue oxygenation." The critical translation of fats in the body The no other than EFA that many polyunsaturates contain is gamma-linoleic acid, yet this doesn't mean that the material substance can translate linoleic acid into the cardiovascular protector, gamma-linolenic acid (GLA). Various factors can stiffen this conversion: a diet heavy in saturated fats, over-use of alcohol, radiation treatments, diabetes, viral infections, cancer, high cholesterol on a levels chemical carcinogens, and a "junk-food" diet cheap in vitamin B-6. From a health-protection stand-point, it is important for this conversion to take place, as GLA is a precursor to prostaglandin E-1 (PGE1) Prostaglandins are short-term regulators of carcass organs and glands. Among its many beneficial parts in our health, PGE1 inhibits inflammation, regulates the immune hypothesis dilates blood vessels and lowers relations pressure, keeps red blood solitary abode; squalid membranes fluid and flexible, and helps to create insulin receptors in cells Evening primrose oil is a natural aid and support to our health and material part systems, because it already has a high ease of GLA, ready for use in the production of prostaglandins. In his acknowledge lab experiments, Horrobin has build that 2-4 g of. evening primrose oil -- four to eight 500-mg capsules -- have a far greater positive result on total blood cholesterol than a great quantity [i]or[/i] amount of higher amounts of other polyunsaturates. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |